Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 242 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)				Phase IV				08-0106 NCT00748085
	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia				Phase III, Phase II				001-0015-211 NCT00127387
	Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis				Phase III, Phase II				20050113 NCT00243685
	Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer				Phase III				RTOG-0320 RTOG-0320, NCT00096265
	Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer				Phase III				CP02-0452 NCT00095199
	Dietary Supplement in Treating Patients Who are Receiving Chemotherapy for Stage III or Stage IV Non-Small Cell Lung Cancer				Phase III				SFC-SV001 SFC-01-0150-0001-02-CM, SFC-01-0150-001, NCT00246727
	Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer				Phase III				NOV002-C301 NCT00347412
	Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases				Phase III				NCCTG-N0574 N0574, ACOSOG-N0574, NCT00377156
	Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer				Phase III				HYT105962 NCT00390806
	A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-Small Cell Lung Cancer				Phase III				CBA-TP0301 NCT00437749


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute